Upendra Rathore

Dr. Upendra Rathore

Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
Durga Prasanna MisraDurga Prasanna Misra
Durga Prasanna Misra
URUpendra Rathore
Upendra Rathore
PPPallavi Patro
Pallavi Patro
VAVikas Agarwal
Vikas Agarwal
ASAman Sharma
Aman Sharma


23 July 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
Durga Prasanna MisraDurga Prasanna Misra
Durga Prasanna Misra
URUpendra Rathore
Upendra Rathore
PPPallavi Patro
Pallavi Patro
VAVikas Agarwal
Vikas Agarwal
ASAman Sharma
Aman Sharma

1 March 2022 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
KSKritika Singh
Kritika Singh
URUpendra Rathore
Upendra Rathore
MRMohit Kumar Rai
Mohit Kumar Rai
MBManas Ranjan Behera
Manas Ranjan Behera
NJNeeraj Jain
Neeraj Jain
Durga Prasanna MisraDurga Prasanna Misra
Durga Prasanna Misra
Purpose: We evaluated T helper lymphocyte profile, including novel Th17 subsets Th17.1 (secrete IFN-γ, associate with corticosteroid resistance) and PD1+Th17 (secrete TGF-β 1, implicated in fibrosis), and related cytokines in peripheral blood of Takayasu arteritis (TAK). Materials and Methods: We evaluated circulating Th1, Th2, Th17, Th17.1, PD1+CD4+ T lymphocytes, PD1+Th17, and Treg lymphocytes, inflammatory (IFN-γ, IL-4, IL-6, IL-17A, IL-23, IL-1β, TNF-α) and regulatory (IL-10, TGF-β 1) cytokines in peripheral blood of TAK (n = 57; median age 35 (interquartile range 26– 45) years; 40 females) in a cross-sectional design. We studied inflammatory and regulatory cytokines in culture supernatant of peripheral blood mononuclear cells (PBMCs) from TAK following stimulation with anti-CD3/anti-CD28 and their modulation by tacrolimus (immunosuppressive) with/without tadalafil (anti-fibrotic). Furthermore, we followed up immunosuppressive-naïve active TAK (n = 16) and compared T helper lymphocyte populations and cytokines before and after immunosuppressive therapy. Healthy controls (HC, n = 21) and sarcoidosis (disease control, n = 11) were compared against TAK. Results: TAK had higher Th17, Th17.1 and PD1+Th17 lymphocytes than HC (p < 0.001), and higher PD1+CD4+ T lymphocytes than sarcoidosis (p < 0.001). Th17 lymphocytes associated with active TAK after multivariable-adjusted logistic regression (p = 0.008). TAK had greater cytokine secretion from PBMCs (IFN-γ, IL-17A, IL-10 versus HC; IL-6, TNF-α, IL-1β versus HC or sarcoidosis) (p < 0.05). In-vitro, PBMCs from TAK showed reduced secretion of all inflammatory cytokines with tacrolimus, with synergistic reduction in IL-17A, IL-6, IL-1β and IL-10 following addition of tadalafil to tacrolimus. Serial follow-up of immunosuppressive-naïve TAK (n = 16) showed reduction in serum IL-6 and TGF-β 1 (p < 0.05) and IL-6 in culture supernatant (p < 0.05) following immunosuppressive therapy. Conclusion: Novel Th17 sub-populations (Th17.1 and PD1+Th17) are elevated in TAK. Th17 lymphocytes associate with active TAK. In-vitro experiments on cultured PBMCs suggest promise for further evaluation of a combination of immunosuppressive tacrolimus with anti-fibrotic tadalafil (or other anti-fibrotic therapies) in clinical trials of TAK.

26 May 2023 in Best Practice & Research Clinical Rheumatology
Verified
Journal Article
Closed access
Durga Prasanna MisraDurga Prasanna Misra
Durga Prasanna Misra
KSKritika Singh
Kritika Singh
URUpendra Rathore
Upendra Rathore
CKChengappa Kavadichanda
Chengappa Kavadichanda
MOManish Ora
Manish Ora
VAVikas Agarwal
Vikas Agarwal

3 November 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
URUpendra Rathore
Upendra Rathore
DTDarpan Radheshyam Thakare
Darpan Radheshyam Thakare
PPPallavi Patro
Pallavi Patro
VAVikas Agarwal
Vikas Agarwal
ASAman Sharma
Aman Sharma
Durga Prasanna MisraDurga Prasanna Misra
Durga Prasanna Misra